Radiotherapy is also known as radiation therapy, which utilizes high-energy radiation to kill cancer cells and reduce tumors. It involves the use of various rays including X-rays, gamma rays, and charged particles. During radiotherapy, radiation can be delivered to the body tissues internally as well as externally. According to the National Cancer Institute, around half of all the cancer patient population receives some type of radiation therapy during their treatment. Research Beam Model: Research Beam Product ID: 1673008 5370 USD New
Radiotherapy Market: Allied Market Research
 

Radiotherapy Market by Type (External Beam Radiation Therapy, Internal Radiation Therapy/Brachytherapy, and Systemic Radiation Therapy), and End User (Hospitals & Clinics and Ambulatory Surgical Centers) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Radiotherapy Market by Type (External Beam Radiation Therapy, Internal Radiation Therapy/Brachytherapy, and Systemic Radiation Therapy), and End User

Category : Medical Devices
Published On : June  2017
Pages : 140

request-discount


TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

Radiotherapy is also known as radiation therapy, which utilizes high-energy radiation to kill cancer cells and reduce tumors. It involves the use of various rays including X-rays, gamma rays, and charged particles. During radiotherapy, radiation can be delivered to the body tissues internally as well as externally. According to the National Cancer Institute, around half of all the cancer patient population receives some type of radiation therapy during their treatment.

The global radiotherapy market was valued at $4,723 million in 2016, and is expected to reach at $7,222 million by 2023, growing at a CAGR of 6.2% from 2017 to 2023. The market is driven by growth in number of cancer patients, increase in geriatric population, rise in adoption of radiotherapy devices and procedures, owing to surge in number of awareness campaigns about the benefits of radiotherapy, and technological advancements in radiotherapy devices. However, lack of skilled personnel and difficulty in tumor visualization restrict the market growth. Conversely, growth opportunities in emerging markets and rise in demand for cancer treatment are expected to provide several opportunities for market growth during the forecast period.

The report segments the market based on type, end user, and region. Based on type, it is divided into external beam radiation therapy, internal radiation therapy/brachytherapy, and systemic radiation therapy. Based on end user, it is categorized into hospitals & clinics and ambulatory surgical centers. Based on region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Colombia, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis and comprehensive analysis of all geographical regions from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis by type helps to understand the various types of devices used for radiotherapy.
  • Key players are profiled and their strategies are analyzed thoroughly to understand competitive outlook of the global market.

KEY MARKET SEGMENTS

BY TYPE

  • External Beam Radiation Therapy
    • By Product
      • Compact Advanced Radiotherapy Systems
        • Cyberknife
        • Gamma Knife
        • Tomotherapy
      • Proton Therapy Systems
      • Conventional Radiotherapy Systems

By Technology

  • Image-Guided Radiotherapy (IGRT)
  • Intensity Modulated Radiotherapy (IMRT)
  • Stereotactic Technology
  • Proton Beam Therapy
  • 3D Conformal Radiotherapy (3D CRT)
  • Volumetric Modulated Arc Therapy (VMAT)

By Application

  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Other
  • Internal Radiation Therapy/Brachytherapy

By Product

  • Seeds & Applicators
  • Electronic Brachytherapy

By Technology

  • Low Dose Rate
  • High Dose Rate

By Application

  • Prostate Cancer
  • Gynecological Cancer
  • Breast Cancer
  • Other
  • Systemic Radiation Therapy

BY END USER

  • Hospitals & Clinics
  • Ambulatory Surgical Centers

BY REGION

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  •  Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Varian Medical Systems, Inc.
  • Elekta AB
  • Accuray Incorporated
  • IBA (Ion Beam Applications Sa)
  • Nordion, Inc.
  • C. R. Bard, Inc.
  • Isoray Medical, Inc.
  • Raysearch Laboratories AB
  • Mevion Medical Systems, Inc.
  • Mitsubishi Electric Corporation

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)

  • Shenzhen GeneMDx Biotech. Co., Ltd.
  • Vision RT Ltd.
  • IntraOp Medical, Inc.
  • Eckert & Ziegler
  • Theragenics Corporation

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Growing number of cancer patients
3.4.1.2. Increasing ageing population
3.4.1.3. Rising awareness and increasing adoption of radiotherapy devices and procedures
3.4.1.4. Technological advancements in radiotherapy devices

3.4.2. Restraints

3.4.2.1. Dearth of skilled personnel
3.4.2.2. Difficulty in tumor visualization

3.4.3. Opportunities

3.4.3.1. Growth opportunities in emerging markets
3.4.3.2. Increasing demand for cancer treatment

3.4.4. Impact analysis

3.5. CLINICAL TRIALS

CHAPTER 4 GLOBAL RADIOTHERAPY MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. EXTERNAL BEAM RADIATION THERAPY

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. External beam radiation therapy market, by product
4.2.5. Market size and forecast

4.2.5.1. Compact advanced radiotherapy systems

4.2.5.1.1. Market size and forecast
4.2.5.1.2. CyberKnife

4.2.5.1.2.1. Market size and forecast

4.2.5.1.3. Gamma Knife

4.2.5.1.3.1. Market size and forecast

4.2.5.1.4. Tomotherapy

4.2.5.1.4.1. Market size and forecast

4.2.5.2. Proton therapy systems

4.2.5.2.1. Market size and forecast

4.2.5.3. Conventional radiotherapy systems

4.2.5.3.1. Market size and forecast

4.2.6. External beam radiation therapy, by technology
4.2.7. Market size and forecast

4.2.7.1. 3D Conformal Radiotherapy (3D CRT)

4.2.7.1.1. Market size & forecast

4.2.7.2. Image-Guided Radiotherapy (IGRT)

4.2.7.2.1. Market size & forecast

4.2.7.3. Intensity Modulated Radiotherapy (IMRT)

4.2.7.3.1. Market size & forecast

4.2.7.4. Stereotactic Technology

4.2.7.4.1. Market size & forecast

4.2.7.5. Proton Beam Therapy

4.2.7.5.1. Market size & forecast

4.2.7.6. Volumetric Modulated Arc Therapy (VMAT)

4.2.7.6.1. Market size & forecast

4.2.8. External beam radiation therapy, by application
4.2.9. Market size & forecast

4.2.9.1. Prostate Cancer

4.2.9.1.1. Market size & forecast

4.2.9.2. Breast Cancer

4.2.9.2.1. Market size & forecast

4.2.9.3. Lung Cancer

4.2.9.3.1. Market size & forecast

4.2.9.4. Colorectal Cancer

4.2.9.4.1. Market size & forecast

4.2.9.5. Other

4.2.9.5.1. Market size & forecast

4.3. INTERNAL RADIATION THERAPY/BRACHYTHERAPY

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Brachytherapy market, by product
4.3.5. Market size and forecast

4.3.5.1. Implants & applicators

4.3.5.1.1. Market size and forecast

4.3.5.2. Electronic brachytherapy devices

4.3.5.2.1. Market size and forecast

4.3.6. Brachytherapy market, by technology
4.3.7. Market size and forecast

4.3.7.1. Low dose rate

4.3.7.1.1. Market size and forecast

4.3.7.2. High dose rate

4.3.7.2.1. Market size and forecast

4.3.8. Brachytherapy market, by application
4.3.9. Market size and forecast

4.3.9.1. Prostate cancer

4.3.9.1.1. Market size and forecast

4.3.9.2. Gynecological cancer

4.3.9.2.1. Market size and forecast

4.3.9.3. Breast cancer

4.3.9.3.1. Market size and forecast

4.3.9.4. Other

4.3.9.4.1. Market size and forecast

4.4. SYSTEMIC RADIATION THERAPY

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

CHAPTER 5 RADIOTHERAPY MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS & CLINICS

5.2.1. Market size and forecast

5.3. AMBULATORY SURGICAL CENTERS (ASCS)

5.3.1. Market size and forecast

CHAPTER 6 RADIOTHERAPY MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S.
6.2.5. Canada
6.2.6. Mexico

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany
6.3.5. France
6.3.6. UK
6.3.7. Italy
6.3.8. Spain
6.3.9. Rest of Europe

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan
6.4.5. China
6.4.6. India
6.4.7. South Korea
6.4.8. Australia
6.4.9. Rest of Asia-Pacific

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil
6.5.5. South Africa
6.5.6. Saudi Arabia
6.5.7. Rest of LAMEA

CHAPTER 7 COMPANY PROFILES

7.1. ACCURAY INCORPORATED

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.7. Key strategic moves and developments

7.2. C. R. BARD, INC.

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Key strategic moves and developments

7.3. ELEKTA AB

7.3.1. Company overview
7.3.2. Company Snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.7. Key strategic moves and developments

7.4. IBA (ION BEAM APPLICATIONS SA)

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Key strategic moves and developments

7.5. ISORAY MEDICAL, INC.

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.7. Key strategic moves and developments

7.6. MEVION MEDICAL SYSTEMS, INC.

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.7. Key strategic moves and developments

7.7. MITSUBISHI ELECTRIC CORPORATION

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Key strategic moves and developments

7.8. NORDION, INC.

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Key strategic moves and developments

7.9. RAYSEARCH LABORATORIES AB

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating product categories
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments

7.10. VARIAN MEDICAL SYSTEMS, INC.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio

LIST OF TABLES

TABLE 1. GLOBAL RADIOTHERAPY MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 2. GLOBAL EXTERNAL BEAM RADIATION THERAPY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. GLOBAL EXTERNAL BEAM RADIATION THERAPY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 4. GLOBAL COMPACT ADVANCED RADIOTHERAPY SYSTEMS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 5. GLOBAL EXTERNAL BEAM RADIATION THERAPY MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 6. GLOBAL EXTERNAL BEAM RADIATION THERAPY MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL INTERNAL RADIATION THERAPY/BRACHYTHERAPY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 8. GLOBAL INTERNAL RADIATION THERAPY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 9. GLOBAL INTERNAL RADIATION THERAPY MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 10. GLOBAL INTERNAL RADIATION THERAPY MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL SYSTEMIC RADIATION THERAPY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 12. GLOBAL RADIOTHERAPY MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 13. RADIOTHERAPY MARKET FOR HOSPITALS & CLINICS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. RADIOTHERAPY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2016-2023 ($MILLION)
TABLE 15. RADIOTHERAPY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 16. CANCER INCIDENCE IN NORTH AMERICA (U.S., CANADA, AND MEXICO)
TABLE 17. NORTH AMERICA RADIOTHERAPY MARKET, BY COUNTRY ($MILLION), 2016-2023
TABLE 18. NORTH AMERICA RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 19. NORTH AMERICA RADIOTHERAPY MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 20. CANCER INCIDENCE IN EUROPEAN UNION (EU-28)
TABLE 21. EUROPE RADIOTHERAPY MARKET, BY COUNTRY ($MILLION), 2016-2023
TABLE 22. EUROPE RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 23. EUROPE RADIOTHERAPY MARKET, BY END USER ($MILLION), 2016-2023
TABLE 24. CANCER INCIDENCE IN ASIA
TABLE 25. ASIA-PACIFIC RADIOTHERAPY MARKET, BY COUNTRY ($MILLION), 2016-2023
TABLE 26. ASIA-PACIFIC RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 27. ASIA-PACIFIC RADIOTHERAPY MARKET, BY END USER ($MILLION), 2016-2023
TABLE 28. CANCER INCIDENCE IN AFRICA
TABLE 29. LAMEA RADIOTHERAPY MARKET, BY COUNTRY ($MILLION), 2016-2023
TABLE 30. LAMEA RADIOTHERAPY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 31. LAMEA RADIOTHERAPY MARKET, BY END USER ($MILLION), 2016-2023
TABLE 37. ACCURAY: COMPANY SNAPSHOT
TABLE 38. ACCURAY: OPERATING SEGMENTS
TABLE 39. C. R. BARD: COMPANY SNAPSHOT
TABLE 40. C. R. BARD: OPERATING SEGMENTS
TABLE 41. ELEKTA: COMPANY SNAPSHOT
TABLE 42. ELEKTA: OPERATING SEGMENTS
TABLE 43. IBA: COMPANY SNAPSHOT
TABLE 44. IBA: OPERATING SEGMENTS
TABLE 45. ISORAY MEDICAL: COMPANY SNAPSHOT
TABLE 46. ISORAY MEDICAL: OPERATING SEGMENTS
TABLE 47. MEVION: COMPANY SNAPSHOT
TABLE 48. MEVION: OPERATING SEGMENTS
TABLE 49. MITSUBISHI ELECTRIC: COMPANY SNAPSHOT
TABLE 50. MITSUBISHI ELECTRIC: OPERATING SEGMENTS
TABLE 51. NORDION: COMPANY SNAPSHOT
TABLE 52. NORDION: OPERATING SEGMENTS
TABLE 53. RAYSEARCH LABORATORIES: COMPANY SNAPSHOT
TABLE 54. RAYSEARCH LABORATORIES: OPERATING SEGMENTS
TABLE 55. VARIAN MEDICAL: COMPANY SNAPSHOT
TABLE 56. VARIAN MEDICAL: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. RADIOTHERAPY MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. MARKET SHARE ANALYSIS, RADIOTHERAPY MARKET, 2016
FIGURE 9. IMPACT ANALYSIS: RADIOTHERAPY MARKET
FIGURE 10. GEOGRAPHICAL DISTRIBUTION OF COMPLETED CLINICAL TRIALS IN RADIOTHERAPY MARKET (%)
FIGURE 11. GLOBAL SYSTEMIC RADIATION THERAPY MARKET, 2016-2023 ($MILLION)
FIGURE 12. U.S. RADIOTHERAPY MARKET ($MILLION), 2016-2023
FIGURE 13. CANADA RADIOTHERAPY MARKET ($MILLION), 2016-2023
FIGURE 14. MEXICO RADIOTHERAPY MARKET ($MILLION), 2016-2023
FIGURE 15. DISTRIBUTION OF THE EUROPEAN UNION (EU) POPULATION AGED 18 OR OVER BY BODY MASS INDEX, 2014 (%)
FIGURE 16. GERMANY RADIOTHERAPY MARKET ($MILLION), 2016-2023
FIGURE 17. FRANCE RADIOTHERAPY MARKET ($MILLION), 2016-2023
FIGURE 18. UK RADIOTHERAPY MARKET ($MILLION), 2016-2023
FIGURE 19. ITALY RADIOTHERAPY MARKET ($MILLION), 2016-2023
FIGURE 20. SPAIN RADIOTHERAPY MARKET ($MILLION), 2016-2023
FIGURE 21. REST OF EUROPE RADIOTHERAPY MARKET ($MILLION), 2016-2023
FIGURE 22. JAPAN RADIOTHERAPY MARKET ($MILLION), 2016-2023
FIGURE 23. CHINA RADIOTHERAPY MARKET ($MILLION), 2016-2023
FIGURE 24. INDIA RADIOTHERAPY MARKET ($MILLION), 2016-2023
FIGURE 25. SOUTH KOREA RADIOTHERAPY MARKET ($MILLION), 2016-2023
FIGURE 26. AUSTRALIA RADIOTHERAPY MARKET ($MILLION), 2016-2023
FIGURE 27. REST OF ASIA-PACIFIC RADIOTHERAPY MARKET ($MILLION), 2016-2023
FIGURE 28. BRAZIL RADIOTHERAPY MARKET ($MILLION), 2016-2023
FIGURE 29. SOUTH AFRICA RADIOTHERAPY MARKET ($MILLION), 2016-2023
FIGURE 30. SAUDI ARABIA RADIOTHERAPY MARKET ($MILLION), 2016-2023
FIGURE 31. REST OF LAMEA RADIOTHERAPY MARKET ($MILLION), 2016-2023

Enquiry Before Buy